EFFICACY OF ADALIMUMAB IN A PATIENT WITH JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS

Abstract

A history case of a female patient with juvenile idiopathic arthritis, resistant to steroids and methotrexate and secondary resistance to infliximab, is represented in this article. Switching to another tumor necrosis factor-alpha inhibitor — adalimumab — led to induction of steady remission of joint syndrome and uveitis, steroids, methotrexate and non-steroidal anti-inflammatory drugs withdrawal.

Keywords

• juvenile idiopathic arthritis
• uveitis
• infliximab
• adalimumab
• tumor necrosis factor-alpha
• secondary resistance
• switching